Aboutus Banner

ABOUT CONFERENCE

The essential subject of Pharmaceutica 2019 is “Research and Innovations in Pharmaceutics and Novel Drug Delivery Systems”. This unique prospect that we outspread to our speakers and attendees are not being offered by any other conference organizers. Through the abstracts and research profiles of our respected speakers and Organizing Committee Members getting global visibility which is an additional feature that our attendees would be receiving in addition to networking opportunities before, throughout and after the conference.

Salient Features

·         Meet University circles and Corporate visionaries to get inspired

·         Enlarge your knowledge and find explanations for problems

·         Knowledge, Benchmarking and Make contacts offered at one place

·         Forge connections and for global networking

·         Highly planned and organized scientific programs

·         Best Oral and Poster presentation ($699/ $399 resp.)

·         Meet with new merchants and traders

The Goals

  • The goals of this conference are to provide a transformative qualified growth experience through bringing together the world’s scientific professionals to catalyze and advance scientific knowledge about Pharmacy and Medicine.
  • Bringing together scientists, researchers, and policy leaders to encourage and enhance programmatic relationships to more effectively address regional, national and local responses to the elderly population around the world and overcome blockades that bound access to care and services.

 

Objectives

·         After participating in this conference, attendees should be able to discuss emerging problems in Pharmacy, Medicine and Healthcare field.

·         Debate and apply recent research discoveries related to Pharmacy, Medicine and Healthcare.

·         Reflect on the place of critical distance in Pharmacy, Medicine and Healthcare.



Market Analysis

Currently, North America has surpassed all the continent in terms of novel drug delivery market in cancer research with a market share of around 38%. Due to excellent research & development in the field of drug delivery system, the exceptional adoption rate of new technologies, helpful reimbursement policy – North America has surpassed all the continents in terms of market share. Europe also holds the 2nd position with a very respective market share of around 29% due to a large number of the cancer patient, development of clinical research facilities, awareness & the novel therapy to the cancer patient.

But Asia is the fastest growing novel delivery market & it shows a huge elevation in growth curve during recent times due to vast research activities, awareness, new therapy procedure, increased no. of the cancer patient in China & Japan. Currently, it holds the 3rd position in the global market with a share of around 20% but in the future, it is expected to boost the market growth.



The total value of global NDDS market in 2016 was $4.31 Billion. The growth is boosted at a rate of 22.9% during the recent period according to CGAR report. The main key drivers of the market growth are a large investment in research & development section of NDDS, increasing no. of cancer patients, awareness, and alternative treatment method etc.



Here is the expected market growth of NDDS up to 2025

However, there are some limitations which ridiculously affect the growth of the novel delivery market. Lack of awareness, an inadequate fund for research & new technologies of  NDDS, fear of habituating in alternative therapy technique retarded the speed of growth of novel drug delivery market. Especially the countries like Mexico, Australia, India mainly facing those type of situation.

Advanced Drug Delivery Systems:

  • The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.
  • The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%.
  • The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.                                                                              

    Our conference “Pharmaceutica 2019” is going to be held in London, UK because London recently becomes the hub of NDDS research & development. A wide range of research works are done by the renowned scientist in London & this UK city has a large number of Pharmaceutical University, colleges & institution. A vast amount of pharmaceutical company & production house also situated in London. At last the main thing is that London has the supply of a sufficient amount of money & top-notch infrastructure for research work & production and development of the new product.


    Target Audience:

    • Drug Delivery Technology Manufacturers
    • Public and Private Physicians
    • Healthcare Institutions (Medical Data Centers)
    • Research & Clinical Laboratories
    • Distributors and Suppliers of Drug Delivery Technologies
    • Health Insurance Payers
    • Market Research and Consulting Firms

     

    Recommended Pharmaceutica 2019 | Pharmacy 2019 | Nanomedicine 2019 | Pharma 2019

    Related Societies UKRoyal Pharmaceutical SocietyThe National Pharmacy Association, United Kingdom Clinical Pharmacy Association, British Pharmacological Society, Epilepsy Society Pharmacy, British Pharmaceutical Students' Association, Commonwealth Pharmacist Association and British Society for the History of Pharmacy.

    Related Societies EuropePharmaceutical Group of the European Union European Society of Clinical Pharmacy,  European Association of Hospital Pharmacists, European Society of Oncology Pharmacy and European CF Pharmacy Group - European Cystic Fibrosis Society.